Cahill Financial Advisors’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-182	Closed	-$11K	–	408
2021 Q3	$11K	Buy	+182	New	+$11K	﹤0.01%	538